You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 752 Developing biomarkers for bexmarilimab, a novel macrophage-guided immunotherapy, in advanced solid tumors to select patients and confirm mechanism of action

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
752 Developing biomarkers for bexmarilimab, a novel macrophage-guided immunotherapy, in advanced solid tumors to select patients and confirm mechanism of action

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023166020
Dec 20235206
Jan 20243301
Feb 20243204
Mar 20242600
Apr 20241806
May 20241604
Jun 2024403
Jul 20241002
Aug 20241407
Sep 20243605
Oct 202434011
Nov 202414010
Dec 20242005
Jan 20253907
Feb 2025001
Mar 2025002
Apr 2025005
May 2025005
Jun 2025002
Total5140106